Warning! GuruFocus detected
2 Severe warning signs
with QL2.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Polypore International Inc
ISIN : US73179V1035
Compare
Compare
Traded in other countries / regions
QL2.Germany Description
Polypore International Inc is a Delaware corporation is a high technology filtration company that develops, manufactures and markets specialized microporous membranes used in separation and filtration processes. The microporous membranes that Company produces are highly engineered polymeric structures that contain millions of pores per square inch, enabling the management of ions, gases and particles that range in size from the cellular to the nano or molecular level. Its operations are mainly managed on a products basis and are comprised of three operating segments that have been aggregated into two reportable segments: energy storage and separations media. The energy storage segment produces and markets membranes that provide the critical function of separating the cathode and anode in a variety of battery markets, including lithium, industrial and transportation applications. The separations media segment produces and markets membranes used as the high technology filtration element in various medical and industrial applications. Electronics applications: The Company develops, manufactures and markets a line of patented polypropylene and polyethylene monolayer and multilayer membrane separators for lithium batteries that are used in numerous applications such as personal electronic devices, cordless power tools and HEVs and other electric vehicles. Transportation and industrial applications: Polypore develops, manufactures and markets a complete line of high-performance polymer-based membrane separators for lead-acid batteries. Approximately 80% of its lead-acid battery separators are used in batteries for automobiles and other motor vehicles. The Company develops, manufactures and markets a complete line of patented polyethersulfone membranes for the hemodialysis market. Hemodialysis is the artificial process that performs the function of a healthy kidney for patients with permanent kidney failure, a condition known as End Stage Renal Disease. Polypore develops, manufactures and markets polypropylene and polymethylpentene membranes for the blood oxygenation market. As a component of heart-lung machines, blood oxygenators temporarily replace the functions of the lungs during on-pump open-heart surgery. The Company develops, manufactures and markets polypropylene and polyethersulfone membranes for the plasmapheresis market. In plasmapheresis, plasma is separated from the blood and either retained for the production of therapeutic proteins or filtered and returned to the blood as a treatment for various autoimmune disorders. Polypore produces a range of membranes and membrane-based elements for micro- and ultrafiltration and gasification/degasification of liquids, covering a range of applications in the filtration market. The Company sells its products and services to customers in both the domestic and international marketplace. Polypore sells mainly to manufacturers and converters that incorporate its products into their finishe
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.1 | |||||
Equity-to-Asset | 0.45 | |||||
Debt-to-Equity | 0.77 | |||||
Debt-to-EBITDA | 3.73 | |||||
Interest Coverage | 5.52 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.16 | |||||
Beneish M-Score | -2.75 |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -3.6 | |||||
3-Year EBITDA Growth Rate | -15.7 | |||||
3-Year EPS without NRI Growth Rate | -30.1 | |||||
3-Year Book Growth Rate | 8.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 12 |
Momentum Rank
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.56 | |||||
Quick Ratio | 1.65 | |||||
Days Inventory | 95.47 | |||||
Days Sales Outstanding | 70.25 | |||||
Days Payable | 25.72 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 1.2 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 34.35 | |||||
Operating Margin % | 11.84 | |||||
Net Margin % | 8.17 | |||||
FCF Margin % | 10.91 | |||||
ROE % | 8.23 | |||||
ROA % | 3.66 | |||||
ROIC % | 5.03 | |||||
ROC (Joel Greenblatt) % | 10.07 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 55.83 | |||||
Forward PE Ratio | 24.69 | |||||
PE Ratio without NRI | 55.83 | |||||
PS Ratio | 4.45 | |||||
PB Ratio | 4.42 | |||||
Price-to-Tangible-Book | 27.19 | |||||
Price-to-Free-Cash-Flow | 39.89 | |||||
Price-to-Operating-Cash-Flow | 23.85 | |||||
EV-to-EBIT | 41.09 | |||||
EV-to-EBITDA | 23.6 | |||||
EV-to-Revenue | 4.87 | |||||
Price-to-Projected-FCF | 3.01 | |||||
Price-to-Median-PS-Value | 1.8 | |||||
Price-to-Peter-Lynch-Fair-Value | 3.64 | |||||
Price-to-Graham-Number | 8.1 | |||||
Earnings Yield (Greenblatt) % | 2.42 | |||||
Forward Rate of Return (Yacktman) % | 16.3 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Polypore International Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 522.016 | ||
EPS (TTM) (€) | 0.937 | ||
Beta | - | ||
3-Year Sharpe Ratio | - | ||
3-Year Sortino Ratio | - | ||
Volatility % | - | ||
14-Day RSI | - | ||
14-Day ATR (€) | - | ||
20-Day SMA (€) | - | ||
12-1 Month Momentum % | - | ||
52-Week Range (€) | 28.74 - 56.3 | ||
Shares Outstanding (Mil) | 45.01 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Polypore International Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Polypore International Inc Stock Events
Event | Date | Price (€) | ||
---|---|---|---|---|
No Event Data |
Polypore International Inc Frequently Asked Questions
What is Polypore International Inc(FRA:QL2)'s stock price today?
The current price of FRA:QL2 is €52.48. The 52 week high of FRA:QL2 is €56.30 and 52 week low is €28.74.
When is next earnings date of Polypore International Inc(FRA:QL2)?
The next earnings date of Polypore International Inc(FRA:QL2) is .
Does Polypore International Inc(FRA:QL2) pay dividends? If so, how much?
Polypore International Inc(FRA:QL2) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |